Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Thrombosis and Haemostasis|July 29, 2024
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance ReviewTruman J Milling, Anna Voronov, Dirk S Schmidt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 28, 2024
Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP<sup>®</sup>/Haemocomplettan<sup>®</sup> P)Niels Rahe-Meyer, Gabriele Neumann, Dirk S Schmidt, et al.The Journal of Thoracic and Cardiovascular Surgery|February 16, 2013
Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trialNiels Rahe-Meyer, Alexander Hanke, Dirk S Schmidt, et al.Journal of the Peripheral Nervous System : JPNS|June 23, 2011
A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept studySiraj A Misbah, Andreas Baumann, Raffaella Fazio, et al.Journal of Clinical Immunology|September 21, 2011
Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter studyMichael Borte, Isabella Quinti, Annarosa Soresina, et al.Anesthesiology|December 20, 2012
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trialNiels Rahe-Meyer, Cristina Solomon, Alexander Hanke, et al.Pageof 1